Evaluation of the Drug-Drug Interaction Potential of Acalabrutinib and Its Active Metabolite, ACP-5862, Using a Physiologically-Based Pharmacokinetic Modeling Approach. (Record no. 29646935)

MARC details
000 -LEADER
fixed length control field 01420 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518035447.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202008s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2163-8306
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/psp4.12408
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Zhou, Diansong
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200812
245 00 - TITLE STATEMENT
Title Evaluation of the Drug-Drug Interaction Potential of Acalabrutinib and Its Active Metabolite, ACP-5862, Using a Physiologically-Based Pharmacokinetic Modeling Approach.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. CPT: pharmacometrics & systems pharmacology
Date of publication, distribution, etc. 07 2019
300 ## - PHYSICAL DESCRIPTION
Extent 489-499 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzamides
General subdivision pharmacokinetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials, Phase I as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Computer Simulation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytochrome P-450 CYP3A Inhibitors
General subdivision pharmacokinetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Interactions
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Models, Biological
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazines
General subdivision pharmacokinetics
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Podoll, Terry
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Xu, Yan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Moorthy, Ganesh
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vishwanathan, Karthick
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ware, Joseph
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Slatter, J Greg
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Al-Huniti, Nidal
773 0# - HOST ITEM ENTRY
Title CPT: pharmacometrics & systems pharmacology
Related parts vol. 8
-- no. 7
-- p. 489-499
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/psp4.12408">https://doi.org/10.1002/psp4.12408</a>
Public note Available from publisher's website

No items available.